A carregar...
The BRAF(V600E) mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy?
OBJECTIVES: Preclinical studies showed that BRAF(V600E) mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy. However, clinical data regarding its role in therapeutic decision making with respect to RAI therapy are currently insufficient...
Na minha lista:
| Publicado no: | Nucl Med Commun |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282664/ https://ncbi.nlm.nih.gov/pubmed/30312216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNM.0000000000000930 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|